DrugPatentWatch Database Preview➤ Subscribe for complete access
« Back to Dashboard
Summary for Patent: 5,869,277
|Title:||Method for measuring type IV collagenase|
|Abstract:||The present invention relates to the development of a modified substrate capture immunoassay useful in the detection of a neutral metalloproteinase enzyme, type IV collagenase. Capture and immobilization of this enzyme can be achieved by coating the microtiter plate with gelatin, an alternative substrate for this enzyme. The captured enzyme can then be detected by affinity purified rabbit anti-type IV collagenase antibodies prepared against synthetic peptides from the amino terminus of the enzyme. Soluble type IV collagenase can readily be detected in samples known to contain this enzyme. Using purified enzyme this assay method can detect less than 50 ng of latent type IV collagenase. Using EDTA, an inhibitor of this metalloproteinase, gelatin binding can be shown to be independent of catalytic activity.|
|Inventor(s):||Stetler-Stevenson; William G. (Gaithersburg, MD), Liotta; Lance (Potomac, MD)|
|Patent Claims:||1. A method of detecting Type IV collagenase in a body fluid test sample comprising the steps of:
a) exposing a solid support having gelatin bound thereto to a body fluid test sample believed to contain Type IV collagenase;
b) exposing the product of step (a) to antibodies against Type IV collagenase;
c) exposing the product of step (b) to an antibody-peroxidase conjugate wherein the antibody of the conjugate is known to be reactive with the antibody which is bound to Type IV collagenase; and
d) exposing the product of step (c) to a peroxidase color development reagent to determine the presence or absence of Type IV collagenase.
2. A method of quantitatively detecting Type IV collagenase in a body fluid comprising the steps of:
a) binding gelatin to solid substrates;
b) exposing the substrate of step (a) to varying amounts of Type IV collagenase or to test samples believed to contain Type IV collagenase;
c) exposing the product of step (b) to antibody which recognizes Type IV collagenase and allowing the antibody to bind to Type IV collagenase;
d) exposing the product of step (c) to antibody-peroxidase conjugates which will bind to the antibody which recognizes Type IV collagenase;
e) exposing the product from step (d) to a peroxidase development reagent; and
f) comparing the response in test samples with substrates having known amounts of Type IV collagenase.
|Applicant||Tradename||Biologic Ingredient||Dosage Form||BLA||Approval Date||Patent No.||Expiredate|
|Smith & Nephew, Inc.||SANTYL||collagenase||Ointment||101995||1965-06-04||⤷ Try it Free||2016-02-09|
|>Applicant||>Tradename||>Biologic Ingredient||>Dosage Form||>BLA||>Approval Date||>Patent No.||>Expiredate|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.